CTXR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CTXR shares is 62, representing 13.17% of the company's common stock.

BARCLAYS PLC, in the last quarter, reduced its stake in CTXR by -44.04% restricting it's holding to 94.47 thousand shares of worth nearly $85.00K. GOLDMAN SACHS GROUP INC also lessened -5.48% of the CTXR shares from its portfolio, reducing its holding to 87.49 thousand shares of worth $78.50K. JANE STREET GROUP, LLC also shunned CTXR shares holding by -20.51% last quarter which brought its holding to 78.45 thousand shares worth $70.39K.

As per its latest 13F filing, increased its stake in CTXR by 100% in the last quarter. The institutional holder raised its holding to 17.5 thousand shares having worth more than $15.70K. BLAIR WILLIAM & CO/IL also added 5.48% more shares of CTXR to its portfolio, raising its holding to 96.2 thousand shares of worth $86.32K. KESTRA ADVISORY SERVICES, LLC also increased its CTXR shares holding by 11.69% which brought its holding to 80.89 thousand shares worth $72.58K.

The insider with the most stakes in CTXR is Mazur Leonard L , Executive Chairman at the company. Additionally, CTXR stock is highly held by President and CEO HOLUBIAK MYRON Z and N/A N/A among others.

Company executives, directors, and other insiders own 6.81% percent of Citius Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CTXR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Citius Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 0 Citius Pharmaceuticals, Inc. shares are held by insiders, which represents about 6.81% of CTXR stock.

CTXR Executive Chairman, Mazur Leonard L holds the largest portfolio of the company's shares. CTXR shares owned by Mazur total nearly 2.23 million.

is the largest institutional owner in CTXR which holds 17.5 thousand shares worth $15.70K or 0.01% of the total CTXR shares outstanding followed by ARKADIOS WEALTH ADVISORS with ownership of 100 thousand shares representing 0.06% of the CTXR ownership. BLAIR WILLIAM & CO/IL is the third largest stakeholder with 96.2 thousand shares or 0.06% of the ownership worth more than $86.32K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CTXR is concerned, it is a stock which is optionable.

Number of CTXR shares short is 523.87K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 8.47M shares of CTXR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CTXR has 158.25M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CTXR is 0.94.